Immediate Impact
37 standout
Citing Papers
Cystic fibrosis
2024 Standout
Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2–5 Years with Cystic Fibrosis and at Least One F508del Allele
2023 Standout
Works of Jacob Twiss being referenced
Longitudinal pulmonary function of childhood bronchiectasis and comparison with cystic fibrosis
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jacob Twiss | 348 | 63 | 39 | 85 | 12 | 393 | |
| Elisabetta Bignamini | 201 | 58 | 62 | 54 | 18 | 344 | |
| H Levison | 378 | 64 | 134 | 44 | 11 | 446 | |
| Birger Norderud Lærum | 232 | 78 | 215 | 40 | 25 | 421 | |
| KC Lødrup Carlsen | 307 | 45 | 239 | 45 | 7 | 416 | |
| Carina Majaesic | 204 | 82 | 160 | 92 | 25 | 426 | |
| Cathy Coates | 330 | 126 | 64 | 29 | 11 | 424 | |
| Christoph Vogtmann | 172 | 40 | 22 | 73 | 13 | 345 | |
| Carl F Haas | 281 | 40 | 23 | 31 | 19 | 399 | |
| Anne‐Marie Gibson | 326 | 139 | 136 | 33 | 8 | 406 | |
| Hanna L. Roiha | 190 | 40 | 113 | 152 | 8 | 403 |
All Works
Login with ORCID to disown or claim papers
Loading papers...